TempraMed Inc

TempraMed Inc manufactures patented thermal protection cases for temperature-sensitive medications, primarily insulin pens, GLP-1 weight-loss medications (Ozempic, Wegovy, Saxenda), and epinephrine auto-injectors (EpiPen). The company's flagship product, VIVI Cap, is a passive insulation case using space-grade heat-absorbing material that maintains safe temperatures (≤86°F / ≤30°C) without batteries, charging, or maintenance for years. VIVI Cap Smart adds digital temperature tracking via built-in sensor with LED indicator. Additional products include VIVI Med (for vials and pens), VIVI Epi (EpiPen-specific), and upcoming VIVI Box (multi-injector storage) and VIVI Cool 8C (pharmaceutical-grade storage). Products are FDA-registered, CE-marked, TSA-approved, and compatible with 50+ insulin pen brands including Humalog, Lantus, Novolog, Tresiba, and reusable pens. The company serves 100,000+ individual customers primarily through direct-to-consumer e-commerce and B2B pharmacy/healthcare partnerships. Clinical validation includes endorsements from Yale pediatric endocrinology and diabetes educators. US-based manufacturer with international distribution expanding to Panama and other markets.